Adrien Holzgreve

27PUBLICATIONS
99CO-AUTHORS
Predictive and prognostic markersVeterinary diagnosis and diagnosticsAboriginal and Torres Strait Islander genomicsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jun 13, 2025
Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma.

Sophie Carina Kunte, Adrien Holzgreve, Marcus Unterrainer

|May 03, 2025
PET imaging utilization and trends in Germany: a comprehensive survey.

Adrien Holzgreve, Dirk Hellwig, Henryk Barthel

|Oct 15, 2024
PET/CT imaging of differentiated and medullary thyroid carcinoma using the novel SSTR-targeting peptide [18F]SiTATE - first clinical experiences.

Sophie C Kunte, Vera Wenter, Johannes Toms

|Aug 16, 2024
Remote Neuroinflammation in Newly Diagnosed Glioblastoma Correlates with Unfavorable Clinical Outcome.

Laura M Bartos, Stefanie Quach, Valerio Zenatti

|May 13, 2024
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome.

Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland

|Jan 23, 2024
The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic Glioblastoma.

Lukas Gold, Enio Barci, Matthias Brendel

Pageof 5

Frequent Collaborators

8 joint publications

Marcus Unterrainer

5 joint publications

Lena Kaiser

4 joint publications

Viktoria Ruf

3 joint publications

Sabrina V Kirchleitner